New patent for Novartis drug SCEMBLIX

   May 14, 2024    Comments Off on New patent for Novartis drug SCEMBLIX    Posted in: Patent Added

Annual Drug Patent Expirations for SCEMBLIX Scemblix is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting…
Source

Continue reading

New patent for Beigene drug BRUKINSA

   May 14, 2024    Comments Off on New patent for Beigene drug BRUKINSA    Posted in: Patent Added

Annual Drug Patent Expirations for BRUKINSA Brukinsa is a drug marketed by Beigene and is included in one NDA. It is available from one supplier. There are eleven patents protecting…
Source

Continue reading
Biotechblog